These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1048 related items for PubMed ID: 25670896

  • 1. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ, Eriksson G, Calverley PM, Jenkins CR, Postma DS, Peterson S, Östlund O, Anzueto A.
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [Abstract] [Full Text] [Related]

  • 2. Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD.
    Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():13-25. PubMed ID: 28031707
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fluticasone propionate/formoterol for COPD management: a randomized controlled trial.
    Papi A, Dokic D, Tzimas W, Mészáros I, Olech-Cudzik A, Koroknai Z, McAulay K, Mersmann S, Dalvi PS, Overend T.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1961-1971. PubMed ID: 28740376
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
    Kuna P, Jenkins M, O'Brien CD, Fahy WA.
    Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
    [Abstract] [Full Text] [Related]

  • 11. Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist.
    Yang HH, Lai CC, Wang YH, Yang WC, Wang CY, Wang HC, Chen L, Yu CJ.
    Int J Chron Obstruct Pulmon Dis; 2017 Apr; 12():2477-2485. PubMed ID: 28860742
    [Abstract] [Full Text] [Related]

  • 12. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.
    J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
    [Abstract] [Full Text] [Related]

  • 13. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M, Pilcher J, Reddel HK, Qi V, Mackey B, Tranquilino T, Shaw D, Black P, Weatherall M, Beasley R, SMART Study Group.
    J Allergy Clin Immunol Pract; 2014 Jun; 2(6):751-8. PubMed ID: 25439367
    [Abstract] [Full Text] [Related]

  • 14. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial.
    Calverley PM, Kuna P, Monsó E, Costantini M, Petruzzelli S, Sergio F, Varoli G, Papi A, Brusasco V.
    Respir Med; 2010 Dec; 104(12):1858-68. PubMed ID: 20965712
    [Abstract] [Full Text] [Related]

  • 15. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
    Bathoorn E, Liesker JJ, Postma DS, Boorsma M, Bondesson E, Koëter GH, Kauffman HF, van Oosterhout AJ, Kerstjens HA.
    COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
    [Abstract] [Full Text] [Related]

  • 16. [Budesonide/formoterol in the treatment of COPD].
    Peces-Barba Romero G, Villar Alvarez F.
    Arch Bronconeumol; 2010 Oct; 46 Suppl 4():22-7. PubMed ID: 20850023
    [Abstract] [Full Text] [Related]

  • 17. A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease.
    Kern DM, Williams SA, Tunceli O, Wessman C, Zhou S, Pethick N, Elhefni H, Trudo F.
    Int J Chron Obstruct Pulmon Dis; 2014 Oct; 9():775-83. PubMed ID: 25071369
    [Abstract] [Full Text] [Related]

  • 18. Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries.
    Nielsen R, Kankaanranta H, Bjermer L, Lange P, Arnetorp S, Hedegaard M, Stenling A, Mittmann N.
    Respir Med; 2013 Nov; 107(11):1709-21. PubMed ID: 23856511
    [Abstract] [Full Text] [Related]

  • 19. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L, Forget A, Ramachandran S.
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.